PanGen Biotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	68,955	75,568	73,520	73,462	69,405	99,783
Market Cap Growth	5.45%	2.79%	0.08%	5.85%	-30.44%	1.96%
Enterprise Value	56,114	63,258	69,814	74,767	67,446	92,638
Last Close Price	5110.00	5600.00	5700.00	6880.00	6500.00	9350.00
PE Ratio	35.00	36.85	77.91	-	-	-
Forward PE	-	91.30	91.30	91.30	91.30	91.30
PS Ratio	5.14	5.63	5.01	10.04	10.68	12.57
PB Ratio	2.30	2.53	2.95	5.85	4.03	4.73
P/TBV Ratio	2.39	2.62	3.05	6.29	4.10	4.80
P/FCF Ratio	-	-	27.99	-	-	-
P/OCF Ratio	363.28	398.12	24.61	-	-	-
EV/Sales Ratio	4.18	4.72	4.76	10.22	10.38	11.67
EV/EBITDA Ratio	18.88	21.29	28.06	-	-	-
EV/EBIT Ratio	37.25	42.00	68.43	-	-	-
EV/FCF Ratio	-150.44	-	26.58	-	-	-
Debt / Equity Ratio	0.03	0.03	0.03	0.16	0	0.89
Debt / EBITDA Ratio	0.32	0.32	0.33	-	-	-
Debt / FCF Ratio	-	-	0.31	-	-	-
Net Debt / Equity Ratio	-0.43	-0.43	-0.43	0.14	-0.05	-0.26
Net Debt / EBITDA Ratio	-4.32	-4.32	-4.26	-0.69	0.28	3.08
Net Debt / FCF Ratio	34.43	34.43	-4.04	-0.47	0.20	1.14
Asset Turnover	0.42	0.42	0.57	0.35	0.20	0.20
Inventory Turnover	1.35	1.35	1.48	0.94	1.07	1.82
Quick Ratio	5.64	5.64	4.98	0.42	1.55	1.28
Current Ratio	8.43	8.43	7.16	1.72	7.59	1.57
Return on Equity (ROE)	7.48%	7.48%	5.04%	-30.14%	-23.46%	-18.75%
Return on Assets (ROA)	2.98%	2.98%	2.49%	-12.75%	-8.97%	-5.17%
Return on Invested Capital (ROIC)	8.59%	9.52%	6.69%	-27.46%	-28.62%	-22.21%
Return on Capital Employed (ROCE)	5.00%	5.00%	3.70%	-28.10%	-23.50%	-14.10%
Earnings Yield	2.97%	2.71%	1.28%	-6.11%	-6.48%	-3.32%
FCF Yield	-0.54%	-0.49%	3.57%	-5.27%	-6.10%	-4.76%
Buyback Yield / Dilution	-22.05%	-22.05%	-7.78%	-0.03%	-4.47%	-6.02%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.